Natus Medical Inc., which makes medical devices used for newborn care, on Monday forecast 2011 results that were generally equal to Wall Street estimates.
Natus said it expects a profit of 77 cents to 80 cents per share, excluding one-time items, and revenue of $247 million to $250 million. According to Thomson Reuters, analysts expect an average profit of 79 cents per share and $249.4 million in revenue. Analyst estimates also typically exclude one-time costs and gains.
The company's estimates exclude amortization expenses related to intangible assets it gained in acquisitions. Natus said those costs will be about $5 million, or 11 cents per share, in 2011. In the first quarter, it expects amortization costs of $1.2 million, or 3 cents per share. Its estimates also exclude acquisition-related restructuring charges.
For the first quarter, Natus forecast an adjusted profit of 10 to 12 cents per share on $56.5 million to $58.5 million in revenue. Analysts forecast a larger profit of 15 cents per share and revenue of $57.9 million.
Shares of Natus Medical slipped 18 cents to $14 in midday trading.